Investec Bank Plc has filed a Form 8.5 regulatory disclosure relating to share dealings in Advanced Medical Solutions Group Plc (AMS.L) conducted on 11th August 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank Plc is acting as Advisor and Joint Broker to Advanced Medical Solutions Group Plc in connection with the relevant offer period.
As an exempt principal trader dealing in a client-serving capacity, Investec is required to publicly disclose its transactions in the securities of parties connected to any active offer.
On 11th August 2026, Investec purchased a total of 36,690 ordinary shares in Advanced Medical Solutions Group Plc across the trading session.
The purchases were transacted at prices ranging from a low of 280.75 pence per share to a high of 281.5 pence per share.
In addition to purchases, Investec also recorded sales of 256,932 ordinary shares in Advanced Medical Solutions Group Plc on the same date.
Those sales were executed at prices ranging between 280 pence and 281.5 pence per share during the dealing period.
No cash-settled derivative transactions, stock-settled derivative transactions, or other dealings such as subscriptions or conversions were reported as part of this disclosure.
Investec confirmed that no indemnity arrangements, option agreements, or other formal or informal understandings relating to the relevant securities were in place that might induce dealing or non-dealing.
The bank further confirmed no agreements or understandings exist relating to voting rights under any option or future acquisition and disposal of securities referenced by any derivative instrument.
The disclosure was filed on 12th August 2026, with contact details provided through Abhishek Gawde for any related regulatory enquiries.
